Evidence map›Paper›PMID 26166480›Full record

ArticleAmerican journal of human genetics2015

THOC2 Mutations Implicate mRNA-Export Pathway in X-Linked Intellectual Disability.

Raman Kumar, Mark A Corbett, Bregje W M van Bon, Joshua A Woenig, Lloyd Weir, Evelyn Douglas, Kathryn L Friend, Alison Gardner, Marie Shaw, Lachlan A Jolly and 21 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in American journal of human genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Global Co-regulatory Cross Talk Between mMolecular neurobiology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. OncogenicScience (New York, N.Y.) · 2023
    Article
  15. Differential expression of mMolecular neurobiology · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Genomic Analysis of Abnormal DNAM Methylation in Parathyroid Tumors.International journal of endocrinology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 9 institutions in 5 countries.

Raman KumarSchool of Paediatrics and Reproductive Health, Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
Mark A CorbettSchool of Paediatrics and Reproductive Health, Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
Bregje W M van BonSchool of Paediatrics and Reproductive Health, Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Joshua A WoenigSchool of Paediatrics and Reproductive Health, Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
Lloyd WeirSchool of Paediatrics and Reproductive Health, Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
Evelyn DouglasGenetics and Molecular Pathology, SA Pathology, North Adelaide, SA 5006, Australia.
Kathryn L FriendGenetics and Molecular Pathology, SA Pathology, North Adelaide, SA 5006, Australia.
Alison GardnerSchool of Paediatrics and Reproductive Health, Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
Marie ShawSchool of Paediatrics and Reproductive Health, Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
Lachlan A JollySchool of Paediatrics and Reproductive Health, Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
Chuan TanSchool of Paediatrics and Reproductive Health, Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
Matthew F HunterMonash Genetics, Monash Medical Centre, Clayton, VIC 3168, Australia; Department of Paediatrics, Monash University, Clayton, VIC 3168, Australia.
Anna HackettGenetics of Learning Disability Service, Hunter Genetics, Waratah, NSW 2298, Australia.
Michael FieldGenetics of Learning Disability Service, Hunter Genetics, Waratah, NSW 2298, Australia.
Elizabeth E PalmerGenetics of Learning Disability Service, Hunter Genetics, Waratah, NSW 2298, Australia.
Melanie LefflerGenetics of Learning Disability Service, Hunter Genetics, Waratah, NSW 2298, Australia.
Carolyn RogersGenetics of Learning Disability Service, Hunter Genetics, Waratah, NSW 2298, Australia.
Jackie BoyleGenetics of Learning Disability Service, Hunter Genetics, Waratah, NSW 2298, Australia.
Melanie BienekDepartment of Human Molecular Genetics, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany.
Corinna JensenDepartment of Human Molecular Genetics, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany.
Griet Van BuggenhoutCenter for Human Genetics, University Hospitals Leuven, Leuven 3000, Belgium.
Hilde Van EschCenter for Human Genetics, University Hospitals Leuven, Leuven 3000, Belgium.
Katrin HoffmannInstitute of Human Genetics, Martin Luther University Halle-Wittenberg, Magdeburger Strasse 2, 06112 Halle (Saale), Germany.
Martine RaynaudINSERM U930, Imaging and Brain, François-Rabelais University, 37000 Tours, France; INSERM U930, Service de Génétique, Centre Hospitalier Régional Universitaire, 37000 Tours, France.
Huiying ZhaoQIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia.
Robin ReedDepartment of Cell Biology, Harvard Medical School, Harvard University, Boston, MA 02115, USA.
Hao HuDepartment of Human Molecular Genetics, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany.
Stefan A HaasDepartment of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany.
Eric HaanSchool of Paediatrics and Reproductive Health, Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia; South Australian Clinical Genetics Service, SA Pathology, North Adelaide, SA 5006, Australia.
Vera M KalscheuerDepartment of Human Molecular Genetics, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany.
Jozef GeczSchool of Paediatrics and Reproductive Health, Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia; School of Molecular and Biomedical Sciences, University of Adelaide, Adelaide, SA 5005, Australia. Electronic address: jozef.gecz@adelaide.edu.au.
University of Adelaide · AUHunter Genetics · AUMax Planck Institute for Molecular Genetics · DESouth Australia Pathology · AUHarvard University · USInserm · FRMartin Luther University Halle-Wittenberg · DEMonash Medical Centre · AUQIMR Berghofer Medical Research Institute · AU

Funding

MECHANISMS OF PREMRNA SPLICING IN HIGHER EUKARYOTESR01GM043375 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI REED, ROBIN E. · 1990 to 2015
$12.6M
NIGMS NIH HHS R01 GM043375
6 · The paper itself

Abstract

Export of mRNA from the cell nucleus to the cytoplasm is essential for protein synthesis, a process vital to all living eukaryotic cells. mRNA export is highly conserved and ubiquitous. Mutations affecting mRNA and mRNA processing or export factors, which cause aberrant retention of mRNAs in the nucleus, are thus emerging as contributors to an important class of human genetic disorders. Here, we report that variants in THOC2, which encodes a subunit of the highly conserved TREX mRNA-export complex, cause syndromic intellectual disability (ID). Affected individuals presented with variable degrees of ID and commonly observed features included speech delay, elevated BMI, short stature, seizure disorders, gait disturbance, and tremors. X chromosome exome sequencing revealed four missense variants in THOC2 in four families, including family MRX12, first ascertained in 1971. We show that two variants lead to decreased stability of THOC2 and its TREX-complex partners in cells derived from the affected individuals. Protein structural modeling showed that the altered amino acids are located in the RNA-binding domains of two complex THOC2 structures, potentially representing two different intermediate RNA-binding states of THOC2 during RNA transport. Our results show that disturbance of the canonical molecular pathway of mRNA export is compatible with life but results in altered neuronal development with other comorbidities.

Indexed as

Models, MolecularActive Transport, Cell NucleusAmino Acid SequenceBase SequenceChromosomes, Human, XHumansMolecular Sequence DataMutation, MissensePedigreeRNA-Binding ProteinsRNA, MessengerSequence Analysis, DNASyndromeX-Linked Intellectual DisabilityRNA-Binding ProteinsRNA, MessengerThoc2 protein, human

Identifiers

PMID26166480
PMCPMC4573269
OpenAlexW1904666106

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.